By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves New Blood Test for Prostate Cancer For Men With PSA Levels Just Above Normal Range
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Diagnostics > FDA Approves New Blood Test for Prostate Cancer For Men With PSA Levels Just Above Normal Range
Diagnostics

FDA Approves New Blood Test for Prostate Cancer For Men With PSA Levels Just Above Normal Range

BarbaraDuck
BarbaraDuck
Share
2 Min Read
SHARE

Perhaps this will add some additional definitive information on the PSA testing which has been in the news frequently for discussion as to imagewhether it should be used for screening or not.  This test appears to add some additional decision making information if any ac

Perhaps this will add some additional definitive information on the PSA testing which has been in the news frequently for discussion as to imagewhether it should be used for screening or not.  This test appears to add some additional decision making information if any actions or treatments are needed/discussed.  Last year at UCLA a new PSA testing format was developed called the A+PSA test so perhaps with both tests more decision making information can be obtained with fewer false positives.  BD




A+PSA New Test For Prostate Cancer Is More Specific and Reduces False-Positives-Study at UCLA

 


A blood test for prostate cancer billed by its manufacturer as “an answer to the current PSA [prostate-specific antigen] testing controversy” has won FDA approval, the company said.

Beckman Coulter said Monday that the agency had okayed its premarket approval application for the so-called Prostate Health Index test, which incorporates measurement of a PSA precursor protein called [-2] pro-PSA along with total and free PSA.

According to the co-discoverer of [-2] pro-PSA, Kevin Slawin, MD, of Memorial Hermann-Texas Medical Center in Houston, the marker is more closely associated with prostate cancer than total and free PSA. Combining the three markers makes the Prostate Health Index more specific than conventional PSA testing.

http://www.medpagetoday.com/HematologyOncology/ProstateCancer/33486

More Read

Exchanging information to enhance patient care
Baystate Health’s Regional HIE Invites Outside Providers to Participate to Help Enhance Patient Care
The Speed Bump Test for Appendicitis
More “Conversations” – Not More Health IT – Are What’s Needed To Increase Patient Engagement And Improve Patient Satisfaction
New Concussion Sensors, Apps Help Without Solving Key Diagnostic Issues
Telemedicine Image Collaboration Enhances Patient Safety


  

TAGGED:prostate cancerscreening
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

Diagnostics

Should Patients Consult Dr. Google?

January 19, 2016
radiologists inattentional blindness
DiagnosticsMedical EducationRadiologySpecialties

Inattentional Blindness and the Invisible Gorilla Study: Are Radiologists at Risk?

March 28, 2013
Global healthcare market
BusinessDiagnosticseHealthFinanceGlobal HealthcareHealth ReformHospital AdministrationMedical DevicesMedical InnovationsMedical RecordsPolicy & LawPublic HealthTechnology

Staying Competitive – Financing Medical Equipment and Technology in the Global Healthcare Market

May 20, 2014
mobile dermatology app
DiagnosticseHealthMobile Health

Over 200 Mobile Apps For Dermatology – But Can “Dr. Mole” Ever Be Truly Accurate…Or Accountable?

October 3, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?